Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019-2021
CONCLUSIONS: Vancomycin, fidaxomicin, and metronidazole remain in vitro effective against clinical C. difficile isolates in Taiwan. The reservoirs and genetic relatedness of two major RTs with zoonotic potentials, RT 078/126 and 014/020, warrant further investigations.PMID:38135646 | DOI:10.1016/j.jmii.2023.12.004
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Chin-Shiang Tsai Po-Liang Lu Min-Chi Lu Tai-Chin Hsieh Wei-Ting Chen Jann-Tay Wang Wen-Chien Ko Source Type: research
More News: Allergy & Immunology | Avelox | Clindamycin | Clostridium Difficile | Genetics | Laboratory Medicine | Metronidazole | Microbiology | Moxifloxacin | Study | Taiwan Health | Xifaxan | Zoonoses